Literature DB >> 18435337

The effect of probe placement and type of viscoelastic material on endoscopic cyclophotocoagulation laser energy transmission.

Jenny Y Yu1, Malik Y Kahook, Kira L Lathrop, Robert J Noecker.   

Abstract

BACKGROUND AND
OBJECTIVE: Endoscopic cyclophotocoagulation is a laser modality used to treat refractory glaucoma through the ablation of ciliary epithelium on the ciliary processes, which results in reduced aqueous production. The purpose of this study was to investigate the effect of various viscoelastics and optimal probe positioning on endoscopic cyclophotocoagulation treatment.
MATERIALS AND METHODS: Six different viscoelastic materials and a balanced salt solution, which was used as a control, were evaluated by placing 2 mL of each in a separate 2 mL glass tube. Laser power was measured at six distances to represent clinical placement of the laser probe in relation to the ciliary processes.
RESULTS: The amount of energy measured with the probe at the bottom of the tube and 1 and 2 mm away was not statistically significantly different among the viscoelastic materials or the balanced salt solution. There was a gradual decrease in transmission of laser energy in all viscoelastics as the laser probe was moved farther away.
CONCLUSION: To preserve the intended laser energy setting, the optimal distance between the treated tissue and the laser probe is 2 mm.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18435337     DOI: 10.3928/15428877-20080301-18

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  3 in total

1.  Cyclodestructive procedures for refractory glaucoma.

Authors:  Monica F Chen; Carole H Kim; Anne L Coleman
Journal:  Cochrane Database Syst Rev       Date:  2019-03-10

2.  Endocyclophotocoagulation.

Authors:  Suzanne M Falkenberry; Carla J Siegfried
Journal:  Middle East Afr J Ophthalmol       Date:  2009-07

3.  A study of the efficacy of endoscopic cyclophotocoagulation for the treatment of refractory glaucomas.

Authors:  Seemant Raizada; Khalid Al Sabti
Journal:  Indian J Ophthalmol       Date:  2009 Sep-Oct       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.